FILE PHOTO: View of Pfizer’s new respiratory syncytial virus (RSV) FILE PHOTO: View of Pfizer’s new respiratory syncytial virus (RSV) vaccine Abrysvo during its manufacture in this undated handout picture. Pfizer/Handout via REUTERS/File Photo Post navigation Previous: EU health regulator backs Pfizer’s RSV vaccine for infants, older adults